We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Pelta Eleanor has been assisting clients through the H1B Visa process since 2017.

As of 2022, Pelta Eleanor has succesfully submitted and recieved certification for 982 cases.

Pelta Eleanor is located in Washington, , and has represented 85 employers for the H1B Visa Process

1,097
Cases Handled
982
Cases Certified
89.52%
Approval

Cases Handled by Pelta Eleanor

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-19074-345176 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19072-565163 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Genpharm International Llc 2019
I-200-19068-766257 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19067-765221 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19067-526786 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19066-000069 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19036-050681 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19028-417872 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-19023-882681 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019
I-200-18339-561180 CERTIFIED Medical Scientists Except Epidemiologists Medicinal And Botanical Manufacturing Bristol Myers Squibb Company 2019